EUCTR2020-005527-36-AT招募中1 期
Human Ezrin Peptide 1 (HEP1) as a therapeutic agent for SARS-CoV-2 (COVID 19) positive patients-a randomized controlled clinical trial
Gesellschaft für Zelltherapie mbH0 个研究点目标入组 100 人开始时间: 2021年1月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •patients hospitalized with a positive SARS-CoV-2 PCR test
- •fever (> 38°C), checked with a standardised ear thermometer
- •=5 and = 8 points on the WHO Clinical Progression Scale
- •signed valid declaration of consent (IC)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •< 18 years old
- •Pregnant or breast-feeding woman (checked by HCG test in serum or urine)
- •History of known hypersensitivity to the study drug or their components
- •Participation in another clinical trial or taking of another investigational drug
- •Other comorbidities in which, in the opinion of the investigator, the risks of administration of the study drug is not acceptable
- •Valid DNR (Do-Not-resuscitate) or DNE (Do- Not Escalate) protocol
- •Patients, who, in the opinion of the investigator, will not survive the next 7 days
研究者
相似试验
已完成
不适用
Heme Oxygenase-1 in Liver Surgeryiver surgery/pharmacological preconditioningSurgeryLiver surgeryISRCTN94278797niversity of Edinburgh (UK)42
进行中（未招募）
1 期
Induction of Heme Oxygenase-1: a therapeutic approach to reduce hepatic ischaemia-reperfusion injury in liver surgery - HOLS studyEUCTR2008-005955-40-GBniversity of Edinburgh42
已完成
1 期
Safety Study of Erythropoietin (EPO) in Parkinson's DiseaseParkinson DiseaseNCT01010802International Center for Neurological Restoration, Cuba10
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines targeting VEGFR1 in patients with advanced renal cell carcinomaadvanced renal cell carcinomaJPRN-UMIN000004911Department of Urology, Kinki University School of Medicine18
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.unresectable colorectal cancerJPRN-UMIN000000956Institute of Medical Science The University of Tokyo6